EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Alloanti‐ H y in antenatal patients: A multi‐case review

S Lewis, N Kirkpatrick, A Nawrocki, L Reyland, B Jones, R Laundy, A McNeil, V Karamatic Crew, T Stutt, D Clinton, A Anbazhagan, C Harris und 3 weitere

Transfusion Medicine · 2025

DOI: 10.1111/tme.13124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transfusion Medicine, 2025. Verfasst von S Lewis und 14 weiteren Autor:innen. Beteiligte Einrichtung: RCI, NHSBT, Birmingham, UK. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Isoantibodies. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Introduction The Hy antigen is one of ten red cell antigens belonging to the Dombrock blood group system, with an antigen frequency of almost 100% in the majority of populations. Alloantibodies to high prevalence antigens cause difficulties with antibody identification and exclusion in serological investigations. Case Presentation This review describes the management of four antenatal cases where the presence of alloanti‐Hy had been identified. Hy‐red blood cell units may be required for the transfusion of patients with alloanti‐Hy, but currently, there are no published reports of alloanti‐Hy causing haemolytic disease of the fetus and newborn (HDFN). A previous case report involving the care and management of antenatal patients with alloanti‐Hy antibodies indicates a lack of evidence that alloanti‐Hy causes clinical HDFN.

Results

All cases discussed in this review demonstrate a reduction in the strength of alloanti‐Hy levels as pregnancy progressed. Signs or symptoms of HDFN were not observed with any of the pregnancies.

Conclusion

Factors such as antibody levels, antigenic expression, and varying clinical responses enhance our understanding of why alloanti‐Hy has not been known to cause clinical HDFN. The cases presented here aim to improve understanding of alloanti‐Hy in pregnancy and how to manage such cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythroblastosis, FetalIsoantibodiesAdultFemaleHumansInfant, NewbornPregnancy

Stichwörter der Autor:innen

DombrockHDFNHyalloanti‐Hy

Substanzen

Isoantibodies

Autor:innen und Institutionen

  • RCI, NHSBT, Birmingham, UK.
  • NIBTS, Belfast, UK.
  • RCI, NHSBT, Liverpool, UK.
  • Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, UK.
  • IBGRL, NHSBT, Filton, UK.
  • CSR Scientific Training, Birmingham, UK.

ORCID-Profile: T Bullock

Zitieren

APA

Lewis, S., Kirkpatrick, N., Nawrocki, A., Reyland, L., Jones, B., Laundy, R., McNeil, A., Crew, V. K., Stutt, T., Clinton, D., Anbazhagan, A., Harris, C., Skidmore, I., Bullock, T., & Hazell, M. (2025). Alloanti‐ H y in antenatal patients: A multi‐case review. Transfusion Medicine. https://doi.org/10.1111/tme.13124

Vancouver

Lewis S, Kirkpatrick N, Nawrocki A, Reyland L, Jones B, Laundy R, et al. Alloanti‐ H y in antenatal patients: A multi‐case review. Transfusion Medicine. 2025. doi:10.1111/tme.13124

BibTeX
@article{Lewis2025,
  author = {Lewis, S and Kirkpatrick, N and Nawrocki, A and Reyland, L and Jones, B and Laundy, R and McNeil, A and Crew, V Karamatic and Stutt, T and Clinton, D and Anbazhagan, A and Harris, C and Skidmore, I and Bullock, T and Hazell, M},
  title = {Alloanti‐ H y in antenatal patients: A multi‐case review},
  journal = {Transfusion Medicine},
  year = {2025},
  doi = {10.1111/tme.13124}
}
Kostenlos starten →